Human Reproduction, Vol. 16, No. 7, 1409-1414,
July 2001
© 2001 European Society of Human Reproduction and Embryology
Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study
1 Tecnobios Procreazione, Centre for Reproductive Health and 2 Department of Obstetrics and Gynaecology, Reproductive Medicine Unit, University of Bologna, Bologna, Italy
BACKGROUND: Partial pituitary desensitization using gonadotrophin-releasing hormone (GnRH) agonists may be sufficient in women undergoing controlled ovarian hyperstimulation for assisted reproduction. However, the minimal effective agonist dose remains to be determined. The aim of the study was to investigate the effect of a reduced daily dose of triptorelin, administered at the start of ovarian stimulation, on the results of IVF and intracytoplasmic sperm injection. METHODS: A total of 132 patients was randomized in two groups. Pituitary desensitization was obtained in group 1 (66 patients) with a single 3.75 mg injection (i.m.) of triptorelin. In group 2, 66 patients received 100 µg triptorelin daily, which was then reduced to 50 µg at the start of follicle-stimulating hormone (FSH) stimulation. RESULTS: No significant differences were found in terms of pregnancy rate per transfer (38% in group 1 versus 34.9% in group 2), implantation rate (20.2 versus 18%) and abortion rate (8.3 versus 9.1%). The number of FSH ampoules used, as well as the number of days stimulation required, was significantly reduced in group 2 (41 ± 26 versus 46.6 ± 25.3, P < 0.03 and 11 ± 1.3 versus 11.8 ± 1.5, P < 0.002 respectively). No significant differences were seen in oestradiol concentrations and in follicle number, in the quantity of oocytes collected and fertilized, or in the number of embryos obtained or transferred. CONCLUSION: A reduced dose of triptorelin is enough for pituitary suppression during ovarian stimulation but provides no significant improvement in IVF cycle outcome when compared with depot formulation. The possibility of a shorter treatment protocol requiring lower amounts of gonadotrophins should be considered in view of its economic advantage.
Key words: GnRH-agonist/IVF/ovarian stimulation/reduced dose/triptorelin
3 To whom correspondence should be addressed at: Tecnobios Procreazione, Center for Reproductive Health, Via Dante 15, I-40125 Bologna, Italy. E-mail: dalprato{at}technobios.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Safdarian, F. S. Mohammadi, A. Alleyassin, M. Aghahosseini, A. Meysamie, and E. Rahimi Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916) Hum. Reprod., September 1, 2007; 22(9): 2449 - 2454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Isikoglu, S. Ozdem, M. Berkkanoglu, H. Jamal, Z. Senturk, and K. Ozgur Single-dose depot leuprolide is as efficient as daily short-acting leuprolide in ICSI cycles Hum. Reprod., June 1, 2007; 22(6): 1657 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Borini, R. Sciajno, V. Bianchi, E. Sereni, C. Flamigni, and G. Coticchio Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration Hum. Reprod., February 1, 2006; 21(2): 512 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Bianchi, G. Coticchio, L. Fava, C. Flamigni, and A. Borini Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration Hum. Reprod., April 1, 2005; 20(4): 1078 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dal Prato, A. Borini, G. Coticchio, M. Cattoli, and C. Flamigni Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study Hum. Reprod., October 1, 2004; 19(10): 2200 - 2205. [Abstract] [Full Text] [PDF]
|
|